When should an adult with a suspected myeloproliferative neoplasm be referred to a hematologist and what initial work‑up is recommended?

When to Refer Adults with Suspected MPN to a Hematologist

Any adult with persistent unexplained cytosis (elevated blood counts lasting >6 months) or clinical features suggestive of myeloproliferative neoplasm should be referred to a hematologist for definitive diagnosis, as bone marrow biopsy with comprehensive molecular testing is required and cannot be adequately performed in primary care 1, 2.

Specific Red Flags Triggering Immediate Referral

Hematologic Abnormalities

• Polycythemia: Elevated hematocrit with suppressed erythropoietin levels
• Thrombocytosis: Persistent platelet count elevation (particularly >600 × 10⁹/L)
• Leukocytosis: Unexplained white blood cell elevation (particularly >15 × 10⁹/L)
• Splenomegaly: Palpable or imaging-confirmed splenic enlargement
• Combination cytosis: Multiple elevated cell lines simultaneously 2

Morphologic Clues on Blood Smear

• Teardrop erythrocytes (dacrocytes) suggesting myelofibrosis
• Granulocytic left shift with dysplasia
• Abnormal megakaryocyte fragments
• Leukoerythroblastic picture 1

Clinical Symptoms

• Unexplained thrombotic events (arterial or venous) in younger patients
• Constitutional symptoms: severe fatigue, night sweats, weight loss, pruritus after bathing
• Symptomatic splenomegaly with early satiety or left upper quadrant pain 3

Recommended Initial Work-Up Before Referral

While definitive diagnosis requires hematology expertise, primary care can initiate:

Laboratory Testing

1. Complete blood count with differential - document persistent abnormalities over time
2. Peripheral blood smear review - look for morphologic features described above
3. Serum erythropoietin level - if polycythemia present (will be suppressed in PV)
4. Basic metabolic panel and liver function tests - exclude secondary causes
5. JAK2 V617F mutation testing - if available, can support referral urgency 2

Important Caveat

Do not delay hematology referral waiting for extensive work-up completion. The diagnostic gold standard remains bone marrow biopsy with morphologic evaluation, cytogenetics, and comprehensive molecular profiling including JAK2, CALR, and MPL mutations 2, 4. These specialized tests and interpretation require hematopathology expertise 5.

Why Hematologist Referral is Essential

The diagnosis of MPN requires integration of:

• Bone marrow morphology: Panmyelosis in PV, megakaryocytic proliferation patterns in ET, reticulin/collagen fibrosis in PMF 2
• Molecular genetics: JAK2, CALR, MPL driver mutations plus comutations affecting prognosis 2
• Clinical correlation: Distinguishing reactive from neoplastic processes 1
• Risk stratification: Determining thrombotic risk and need for cytoreduction 3

The genomic landscape is complex beyond the three driver mutations, with additional mutations in tumor-suppressor genes affecting phenotype, progression risk, and treatment selection 2. This complexity necessitates specialist evaluation.

Timing Considerations

• Urgent referral (within 2 weeks): Symptomatic patients, extreme cytosis, thrombotic complications, or concerning blood smear findings
• Routine referral (within 4-6 weeks): Persistent unexplained cytosis >6 months without acute symptoms 6

The European LeukemiaNet guidelines emphasize that proper diagnosis and risk stratification directly impact treatment decisions—from simple phlebotomy and aspirin in low-risk PV to cytoreductive therapy in high-risk disease 7, 3. Misdiagnosis or delayed diagnosis can result in preventable thrombotic events, which occurred in 9.8% of inadequately controlled PV patients versus 2.7% in properly managed patients 3.